Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
156.92 M EUR
7.21 B EUR
291.12 M
About GRIFOLS
Sector
CEO
Nacho Abia
Headquarters
Barcelona
Website
Founded
1940
ISIN
ES0171996087
Grifols SA engages in the production of plasma derivatives. It operates through the following segments: Bioscience, Hospital, Diagnostic, Bio Supplies, and Others. The Bioscience Segment includes all activities related with products deriving from human plasma for therapeutic use. The Hospital Segment comprises of all non-biological pharmaceutical products and medical supplies manufactured by group companies earmarked for hospital pharmacy. The Diagnostic Segment deals with the marketing of diagnostic testing equipment, reagents, and other equipment. The Bio Supplies segment consists of all transactions related to biological products for non-therapeutic use. The Others segment focuses on the rendering of manufacturing services to third party companies. The company was founded by José Antonio Grifols Roig on November 18, 1940 and is headquartered in Barcelona, Spain.
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Frequently Asked Questions
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange GRIFOLS stocks are traded under the ticker 1GRF.
1GRF stock hasn't changed in a week, the last month showed zero change in price, over the last year there was no change in GRIFOLS price.
We've gathered analysts' opinions on GRIFOLS future price: according to them, 1GRF price has a max estimate of 25.00 EUR and a min estimate of 9.00 EUR. Watch 1GRF chart and read a more detailed GRIFOLS stock forecast: see what analysts think of GRIFOLS and suggest that you do with its stocks.
1GRF stock is 0.00% volatile and has beta coefficient of 0.71. Track GRIFOLS stock price on the chart and check out the list of the most volatile stocks — is GRIFOLS there?
Today GRIFOLS has the market capitalization of 7.09 B, it has increased by 0.63% over the last week.
Yes, you can track GRIFOLS financials in yearly and quarterly reports right on TradingView.
GRIFOLS is going to release the next earnings report on May 1, 2025. Keep track of upcoming events with our Earnings Calendar.
1GRF earnings for the last quarter are 0.23 EUR per share, whereas the estimation was 0.22 EUR resulting in a 3.47% surprise. The estimated earnings for the next quarter are 0.16 EUR per share. See more details about GRIFOLS earnings.
GRIFOLS revenue for the last quarter amounts to 1.98 B EUR, despite the estimated figure of 1.94 B EUR. In the next quarter, revenue is expected to reach 1.72 B EUR.
1GRF net income for the last quarter is 68.97 M EUR, while the quarter before that showed 51.69 M EUR of net income which accounts for 33.42% change. Track more GRIFOLS financial stats to get the full picture.
GRIFOLS dividend yield was 0.00% in 2024, and payout ratio reached 0.00%. The year before the numbers were 0.00% and 0.00% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Mar 9, 2025, the company has 23.83 K employees. See our rating of the largest employees — is GRIFOLS on this list?
Like other stocks, 1GRF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade GRIFOLS stock right from TradingView charts — choose your broker and connect to your account.